At a glance
ClinicalIndex Comparison RecordN/ACompleted· 228 enrolled
Drug / intervention
EmboTrap® Revascularization Devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
In Brief
A clinical study evaluating EmboTrap® Revascularization Device for Stroke and Ischemia. Completed, enrolled 228 participants across 12 sites in 4 countries.
Detailed Summary
The study objective is to examine the recanalization efficacy of the EmboTrap device and its associated performance characteristics and to record associated clinical outcomes in a manner that facilitates relevant comparison of outputs with that of devices approved in the U.S. for clearing Large Vessel Occlusions.
Study Details
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJul 2015
Enrollment StartNov 2015
Primary CompletionMay 2017
Study CompletionSep 2017
TodayJul 2026
First PostedJul 2, 2015
Enrollment StartNov 1, 2015
Primary CompletionMay 1, 2017
Study CompletionSep 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 11 years ago
Interventions
EmboTrap® Revascularization Devicedevice